Latest Biopharmaceutical Sales News

Page 1 of 1

Immuron Posts 16% Q3 Sales Growth on Travelan Expansion Amid Currency Headwinds

Immuron Limited’s unaudited Q3 FY26 sales rose 16% to AUD 1.5 million, driven by Travelan’s expanding footprint in Australia, Canada, and the US despite a stronger Australian dollar.

Ada Torres

17 Apr 2026

Top